Arcutis Latest News
- 15:40 AInvest WireArcutis's 15-minute chart indicates Bollinger Bands expanding downward and KDJ death cross.
- 12:47 AInvest WireArcutis's 15min chart signals potential volatility with MACD Death Cross and BB Narrowing.
- 03-12 AInvest WireArcutis Biotherapeutics Continues to Outperform with Topical Dermatology Leadership.
- 03-12 AInvest WireArcutis Biotherapeutics Outperforms Medical Stocks in 2023
- 03-12 AInvest WireEdenred Appoints Duperat-Vergne as Executive VP Finance, Tanguy to Depart on March 28th.
- 03-11 AInvest NewsArcutis: Jefferies maintains a 'Buy' Rating, The Target Price is $19
- 03-11 AInvest WireArcutis: Jefferies raises buy rating to $19 from $16.
- 03-11 AInvest Exclusive"Revolutionizing the Future of Design: Arcadis Launches 'The Design Perspective'"
- 03-07 AInvest WireArcutis Faces Downward Trend with MACD Death Cross and KDJ Death Cross
- 03-07 NasdaqArcutis to Highlight Data from Phase 3 Trials for Scalp and Body Psoriasis and Atopic Dermatitis at the 83rd American Academy of Dermatology Meeting
- 03-05 AInvest WireAnalysts See 48.36% Upside in Arcutis Biotherapeutics (ARQT): Is the Stock Ready for a Surge?
- 03-05 NasdaqWall Street Analysts See a 48.36% Upside in Arcutis Biotherapeutics (ARQT): Can the Stock Really Move This High?
- 03-05 AInvest WireArcadis CFO Announces Departure and Succession Plan
- 03-05 AInvest NewsInsider Transactions Reported | Arcutis(ARQT)saw insider trading activity on 3/4/2025
- 03-04 AInvest WireArcutis Biotherapeutics Director Sells 10,000 Shares Amid 38 Insider Sales and 3 Buys.
- 03-04 AInvest WireArcutis Biotherapeutics Executives Sell Shares Amid Recent Volatility
- 03-04 AInvestArcutis's 15min chart shows KDJ Golden Cross, bullish Marubozu signal.
- 03-04 AInvest WireArcutis RSI Overbought, KDJ Death Cross on 15-minute chart.
- 03-04 AInvest WireArcadis Lands Lead Design Role for QEII Halifax Infirmary Expansion Project
Show More News
